Ugint Co Ltd Total Liabilities

Latest as of June 2026: ₩23.93 Billion KRW ≈ $16.22 Million USD

Ugint Co Ltd total liabilities. Based on the latest financial reports, Ugint Co Ltd (195990) has total liabilities worth ₩23.93 Billion KRW (≈ $16.22 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 195990 financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Ugint Co Ltd (2014–2025)

Total liabilities of Ugint Co Ltd from 2014 to 2025. This chart illustrates how Ugint Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 195990 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Ugint Co Ltd Competitors by Total Liabilities

The table below lists competitors of Ugint Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Bitcoin Well Inc
V:BTCW
Canada CA$43.02 Million
Sadbhav Infrastructure Project Limited
NSE:SADBHIN
India Rs56.20 Billion
Lichen China Limited Class A Ordinary Shares
NASDAQ:LICN
USA $5.02 Million
TIMES CHINA HLDGS HD -10
F:T2H
Germany €93.24 Billion
Euro Tech Holdings Company Ltd
NASDAQ:CLWT
USA $4.75 Million
Sarthak Metals Limited
NSE:SMLT
India Rs127.36 Million
E-H.(CH)ENT. H. DL-00001
F:1VC
Germany €10.03 Billion
Loyal Solutions AS
ST:LOYAL
Sweden Skr53.10 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Ugint Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Ugint Co Ltd (195990) total assets.

Liquidity & Leverage Metrics

Ugint Co Ltd Total Liabilities Ratios Explained

Ugint Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.71 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.46 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.32 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ugint Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ugint Co Ltd (2014–2025)

The table below shows the annual total liabilities of Ugint Co Ltd from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 ₩20.75 Billion
≈ $14.06 Million
-37.60%
2024-12-31 ₩33.25 Billion
≈ $22.53 Million
+68.19%
2023-12-31 ₩19.77 Billion
≈ $13.40 Million
+20.18%
2022-12-31 ₩16.45 Billion
≈ $11.15 Million
-45.79%
2021-12-31 ₩30.34 Billion
≈ $20.56 Million
+12.68%
2020-12-31 ₩26.93 Billion
≈ $18.25 Million
-61.91%
2019-12-31 ₩70.70 Billion
≈ $47.91 Million
+1.59%
2018-12-31 ₩69.59 Billion
≈ $47.16 Million
-6.33%
2017-12-31 ₩74.29 Billion
≈ $50.35 Million
+30.88%
2016-12-31 ₩56.77 Billion
≈ $38.47 Million
+71.06%
2015-12-31 ₩33.18 Billion
≈ $22.49 Million
-36.93%
2014-12-31 ₩52.62 Billion
≈ $35.66 Million
--

About Ugint Co Ltd

KQ:195990 Korea Specialty Industrial Machinery
Market Cap
$10.23 Million
₩15.09 Billion KRW
Market Cap Rank
#26871 Global
#2016 in Korea
Share Price
₩927.00
Change (1 day)
-8.31%
52-Week Range
₩140.00 - ₩2415.00
All Time High
₩3950.00
About

RootK Co., Ltd. manufactures and sells machine tools and biotechnology products in South Korea and internationally. It offers tapping centers, spindle machines, machining and turning centers, and machining centers with long table. Additionally, It also offers bispecific antibody therapeutics for ophthalmic and oncology indications, including anti-VEGF/ANG2, anti-HER2/CD3, anti-GPC3/CD3, and anti-… Read more